| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.25 | 0.0001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.24 | 0.0002 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |